Andexxa
AstraZeneca’s phase 4 trial stopped early after reaching pre-specified criteria
June 5, 2023Research and Development ANNEXA-I, Andexxa, AstraZeneca, Neurology, clinical trial
AstraZeneca has announced that its post-marketing phase 4 ANNEXA-I trial has been stopped early after reaching its pre-specified stopping criteria. …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
